Illumina, Inc. vs Otis Worldwide Corp — how do they compare? Illumina, Inc. trades at $192.7 (market cap $27.94B), while Otis Worldwide Corp trades at $72.17 (market cap $28.20B). The key difference: Illumina, Inc. and Otis Worldwide Corp are close in size by market cap, and Otis Worldwide Corp pays a 2.31% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | OTIS | |
|---|---|---|
Market Cap | $27.94B | $28.20B |
Sector | Health | Industrials |
52-Week High | $194.33 | $100.99 |
52-Week Low | $91.00 | $69.34 |
Enterprise Value | $29.33B | $35.58B |
Dividend Yield | — | 2.31% |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →